Ketoconazole, 98%
Ketoconazole, 98%
Ketoconazole, 98%

Ketoconazole, 98%

Ketoconazole, CAS # 65277-42-1, is a synthetic, broad-spectrum antifungal agent with the ability to inhibit a variety of fungal infections. | CAS: 65277-42-1 | C26H28Cl2N4O4 | 531.44 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
25 g
1 g
Catalog number FSA455470250
View Price:Sign in to see your account pricing. Need an account? Register with us today.
Quantity:
25 g
Request bulk or custom format
Specifications
Chemical Name or MaterialKetoconazole
CAS65277-42-1
Health Hazard 1GHS Signal Word: Danger
Health Hazard 2GHS H Statement
May damage fertility.
Toxic if swallowed.
May cause damage to organs through prolonged or repeated exposure if swallowed.
Very toxic to aquatic life with long lasting effects.
Health Hazard 3GHS P Statement
Obtain special instructions before use.
Use personal protective equipment as required.
IF exposed or concerned: Get medical advice/attention.
Do not get in eyes,on skin,or on clothing.
Do not eat,drink or smoke
View more
This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General Description

  • Ketoconazole is an imidazole antifungal agent
  • It functions by inhibiting synthesis of ergosterol, which is the fungal equivalent of cholesterol

Applications

  • Ketoconazole shows fungicide activity against a variety of yeast infections
  • It is an inhibitor of CYP3A4, which is necessary for the conversion of lanosterol to ergosterol
  • It increases fungal cellular permeability
  • It also inhibits endogenous respiration by disrupting membrane phospholipids
  • Ketoconazole can also inhibit the synthesis of thromboxane and sterols such as aldosterone, cortisol, and testosterone
RUO – Research Use Only

General References:

  1. Takano, M.; Hasegawa, R.; Fukuda, T.; Yumoto, R.; Nagai, J.; Murakami, T. Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. European Journal of Pharmacology.1998, 358 (3), 289-294.
  2. Goeders, N. E.; Peltier, R. L.; Guerin, G. F. Ketoconazole reduces low dose cocaine self-administration in rats. Drug and Alcohol Dependence.1998, 53 (1), 67-77.